[HTML][HTML] Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: Systematic review and meta-analysis
KR Bainey, G Marquis-Gravel, BJ MacDonald… - Plos one, 2023 - journals.plos.org
Introduction Dual antiplatelet therapy (DAPT) following percutaneous coronary intervention
(PCI) reduces major adverse cardiovascular events (MACE) and stent thrombosis. However …
(PCI) reduces major adverse cardiovascular events (MACE) and stent thrombosis. However …
Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: Systematic review and meta-analysis
KR Bainey, G Marquis-Gravel, BJ MacDonald… - PLoS …, 2023 - ui.adsabs.harvard.edu
Introduction Dual antiplatelet therapy (DAPT) following percutaneous coronary intervention
(PCI) reduces major adverse cardiovascular events (MACE) and stent thrombosis. However …
(PCI) reduces major adverse cardiovascular events (MACE) and stent thrombosis. However …
Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: Systematic review and meta-analysis
K Bainey, G Marquis-Gravel, B MacDonald, D Bewick… - Plos one, 2023 - europepmc.org
Methods We searched MEDLINE, Embase and CENTRAL up to August 18, 2022.
Randomized controlled trials (RCTs) comparing short DAPT (1–3 months) versus standard …
Randomized controlled trials (RCTs) comparing short DAPT (1–3 months) versus standard …
[HTML][HTML] Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: Systematic review and meta-analysis
KR Bainey, G Marquis-Gravel, BJ MacDonald… - PLOS …, 2023 - ncbi.nlm.nih.gov
Methods We searched MEDLINE, Embase and CENTRAL up to August 18, 2022.
Randomized controlled trials (RCTs) comparing short DAPT (1–3 months) versus standard …
Randomized controlled trials (RCTs) comparing short DAPT (1–3 months) versus standard …
Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: Systematic review and meta-analysis
KR Bainey, G Marquis-Gravel, BJ MacDonald… - PloS …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Dual antiplatelet therapy (DAPT) following percutaneous coronary intervention
(PCI) reduces major adverse cardiovascular events (MACE) and stent thrombosis. However …
(PCI) reduces major adverse cardiovascular events (MACE) and stent thrombosis. However …
Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: Systematic review and meta-analysis.
KR Bainey, G Marquis-Gravel, BJ MacDonald… - PLoS …, 2023 - search.ebscohost.com
Introduction: Dual antiplatelet therapy (DAPT) following percutaneous coronary intervention
(PCI) reduces major adverse cardiovascular events (MACE) and stent thrombosis. However …
(PCI) reduces major adverse cardiovascular events (MACE) and stent thrombosis. However …
Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: Systematic review and meta-analysis.
KR Bainey, G Marquis-Gravel, BJ MacDonald… - PLoS ONE, 2023 - go.gale.com
Introduction Dual antiplatelet therapy (DAPT) following percutaneous coronary intervention
(PCI) reduces major adverse cardiovascular events (MACE) and stent thrombosis. However …
(PCI) reduces major adverse cardiovascular events (MACE) and stent thrombosis. However …
Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: Systematic review and meta-analysis.
KR Bainey, G Marquis-Gravel, BJ MacDonald… - Plos one, 2023 - europepmc.org
Methods We searched MEDLINE, Embase and CENTRAL up to August 18, 2022.
Randomized controlled trials (RCTs) comparing short DAPT (1-3 months) versus standard …
Randomized controlled trials (RCTs) comparing short DAPT (1-3 months) versus standard …